Advertisement
Advertisement
Buy Rating Affirmed for Scholar Rock Holding Amid Manufacturing Challenges and Strong Market Potential
PremiumRatingsBuy Rating Affirmed for Scholar Rock Holding Amid Manufacturing Challenges and Strong Market Potential
1M ago
Scholar Rock falls -12.3%
Premium
The Fly
Scholar Rock falls -12.3%
1M ago
Scholar Rock falls -22.7%
Premium
The Fly
Scholar Rock falls -22.7%
1M ago
Scholar Rock price target lowered to $44 from $45 at Barclays
PremiumThe FlyScholar Rock price target lowered to $44 from $45 at Barclays
2M ago
Morning News Wrap-Up: Tuesday’s Biggest Stock Market Stories!
Premium
Market News
Morning News Wrap-Up: Tuesday’s Biggest Stock Market Stories!
2M ago
Scholar Rock price target lowered to $44 from $50 at H.C. Wainwright
Premium
The Fly
Scholar Rock price target lowered to $44 from $50 at H.C. Wainwright
2M ago
Scholar Rock receives CRL from FDA for apitegromab BLA
PremiumThe FlyScholar Rock receives CRL from FDA for apitegromab BLA
2M ago
Scholar Rock initiated with an Overweight at Barclays
Premium
The Fly
Scholar Rock initiated with an Overweight at Barclays
2M ago
Scholar Rock initiated with an Overweight at Barclays
Premium
The Fly
Scholar Rock initiated with an Overweight at Barclays
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100